Lodha Group launches residences with decks and private gardens in Thane

A recent report has said that as many as 81.5 percent survey respondents consider open spaces a ‘must-have’ in developments post COVID-19 and the focus on work-from-home.

Moneycontrol News

Mumbai-based Lodha Group has announced its premium lifestyle project, Casa Greenwood in Amara at Thane. The project would feature facilities like decks and private gardens, bigger houses, and proximity to the two-acre forest land developed inside the community.

Price of units start at Rs 1.08 crore.

A recent report said as many as 81.5 percent survey respondents consider open spaces a ‘must-have’ in developments post COVID-19 and the focus on work-from-home.

A whopping 90.2 percent participants vouch for homes with decks or balconies and 80.1 percent are actively looking for multi-purpose usable spaces within their homes. Over three-fourths of respondents need homes that have additional space to accommodate full-time help.

With homes becoming the sole space for all activities, there is a need for extra rooms as consumers look to create activity driven arenas like a study room or workout space within their homes. Further, residences having private gardens and homes with decks/balconies are being preferred for the much needed fresh air.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show